Table 3.
Clinical and laboratory parameters at baseline.
| Parameter | Study group (n=30) | Control group (n=30) | P |
|---|---|---|---|
| Mean arterial pressure (mm Hg) | 85.1 (13.2) | 89.8 (9.3) | .11 |
| Heart rate (bpm) | 88.3 (12.4) | 86.9 (11.02) | .63 |
| Temperature (°C) | 37.3 (0.4) | 37.2 (0.5) | .70 |
| Respiratory rate (breaths/min) | 14.1 (1.8) | 14.1 (1.8) | .94 |
| Total leukocyte count (109/L) | 11.9 (6.5) | 10.3 (3.5) | .23 |
| Platelet (109/L) | 260.8 (117.6) | 263.2 (126.2) | .94 |
| Alanine aminotransferase (U/L) | 19.9 (8.3) | 24.3 (10.7) | .085 |
| Serum creatinine (μmol/L) | 78.7 (32.2) | 73.7 (23.8) | .49 |
| Blood urea nitrogen (mmol/L) | 4.3 (1.6) | 4.0 (1.9) | .59 |
| Serum sodium (mmol/L) | 137.2 (3.6) | 135.8 (5.2) | .23 |
| Serum potassium (mmol/L) | 4.0 (0.5) | 4.0 (0.5) | .84 |
| TNF-α (ng/L) | 171.3 (68.7) | 167.4 (61.9) | .81 |
| MDA (μmol/L) | 0.8 (0.3) | 0.6 (0.3) | .14 |
Values are means (standard deviation), TNF-α = tumor necrosis factor alpha, MDA = malondialdehyde.